A prospective investigation of coffee drinking and endometrial cancer incidence

Marc J. Gunter, Jennifer A. Schaub, Xiaonan (Nan) Xue, Neal D. Freedman, Mia M. Gaudet, Thomas E. Rohan, Albert R. Hollenbeck, Rashmi Sinha

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Coffee drinking may be associated with reduced risk of endometrial cancer; however, prospective data are limited. Further, it is not clear whether any association between coffee and endometrial cancer differs according to coffee caffeine content. The association of coffee drinking with incidence of endometrial cancer was evaluated among 226,732 women, aged 50-71, enrolled in the NIH-AARP Diet and Health Study who completed a baseline epidemiologic questionnaire. Following a mean 9.3 years of follow-up, data were available for 1,486 incident endometrial cancer cases. Cox proportional hazards models were used to estimate associations of coffee with endometrial cancer incidence. Sub-group analyses were performed according to smoking status, hormone therapy use (HT) and body habitus. Coffee drinking was inversely related to incidence of endometrial cancer (hazard ratio [HR] comparing drinking of >3 cups/day versus no cups = 0.64, 95% CI, 0.51-0.80; P trend = 0.0004). The association of coffee with endometrial cancer risk was apparent for consumption of both regular (HR per cup = 0.90, 95% CI, 0.86-0.95) and decaffeinated coffee (HR per cup = 0.93, 95% CI, 0.87-0.99). The relation of coffee with endometrial cancer incidence varied significantly by HT use (P interaction = 0.03) with an association only apparent among HT-never users (HR comparing drinking >3 cups/day versus no cups = 0.54, 95% CI, 0.41-0.72; P trend = 0.0005). Endometrial cancer incidence appears to be reduced among women that habitually drink coffee, an association that does not differ according to caffeine content.

Original languageEnglish (US)
JournalInternational Journal of Cancer
Volume131
Issue number4
DOIs
StatePublished - Aug 15 2012

Fingerprint

Coffee
Endometrial Neoplasms
Drinking
Incidence
Hormones
Caffeine
Proportional Hazards Models
Therapeutics
Smoking
Diet

Keywords

  • chemoprevention
  • coffee
  • endometrial cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A prospective investigation of coffee drinking and endometrial cancer incidence. / Gunter, Marc J.; Schaub, Jennifer A.; Xue, Xiaonan (Nan); Freedman, Neal D.; Gaudet, Mia M.; Rohan, Thomas E.; Hollenbeck, Albert R.; Sinha, Rashmi.

In: International Journal of Cancer, Vol. 131, No. 4, 15.08.2012.

Research output: Contribution to journalArticle

Gunter, Marc J. ; Schaub, Jennifer A. ; Xue, Xiaonan (Nan) ; Freedman, Neal D. ; Gaudet, Mia M. ; Rohan, Thomas E. ; Hollenbeck, Albert R. ; Sinha, Rashmi. / A prospective investigation of coffee drinking and endometrial cancer incidence. In: International Journal of Cancer. 2012 ; Vol. 131, No. 4.
@article{bbad287e73524d2a8249f77d80655283,
title = "A prospective investigation of coffee drinking and endometrial cancer incidence",
abstract = "Coffee drinking may be associated with reduced risk of endometrial cancer; however, prospective data are limited. Further, it is not clear whether any association between coffee and endometrial cancer differs according to coffee caffeine content. The association of coffee drinking with incidence of endometrial cancer was evaluated among 226,732 women, aged 50-71, enrolled in the NIH-AARP Diet and Health Study who completed a baseline epidemiologic questionnaire. Following a mean 9.3 years of follow-up, data were available for 1,486 incident endometrial cancer cases. Cox proportional hazards models were used to estimate associations of coffee with endometrial cancer incidence. Sub-group analyses were performed according to smoking status, hormone therapy use (HT) and body habitus. Coffee drinking was inversely related to incidence of endometrial cancer (hazard ratio [HR] comparing drinking of >3 cups/day versus no cups = 0.64, 95{\%} CI, 0.51-0.80; P trend = 0.0004). The association of coffee with endometrial cancer risk was apparent for consumption of both regular (HR per cup = 0.90, 95{\%} CI, 0.86-0.95) and decaffeinated coffee (HR per cup = 0.93, 95{\%} CI, 0.87-0.99). The relation of coffee with endometrial cancer incidence varied significantly by HT use (P interaction = 0.03) with an association only apparent among HT-never users (HR comparing drinking >3 cups/day versus no cups = 0.54, 95{\%} CI, 0.41-0.72; P trend = 0.0005). Endometrial cancer incidence appears to be reduced among women that habitually drink coffee, an association that does not differ according to caffeine content.",
keywords = "chemoprevention, coffee, endometrial cancer",
author = "Gunter, {Marc J.} and Schaub, {Jennifer A.} and Xue, {Xiaonan (Nan)} and Freedman, {Neal D.} and Gaudet, {Mia M.} and Rohan, {Thomas E.} and Hollenbeck, {Albert R.} and Rashmi Sinha",
year = "2012",
month = "8",
day = "15",
doi = "10.1002/ijc.26482",
language = "English (US)",
volume = "131",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - A prospective investigation of coffee drinking and endometrial cancer incidence

AU - Gunter, Marc J.

AU - Schaub, Jennifer A.

AU - Xue, Xiaonan (Nan)

AU - Freedman, Neal D.

AU - Gaudet, Mia M.

AU - Rohan, Thomas E.

AU - Hollenbeck, Albert R.

AU - Sinha, Rashmi

PY - 2012/8/15

Y1 - 2012/8/15

N2 - Coffee drinking may be associated with reduced risk of endometrial cancer; however, prospective data are limited. Further, it is not clear whether any association between coffee and endometrial cancer differs according to coffee caffeine content. The association of coffee drinking with incidence of endometrial cancer was evaluated among 226,732 women, aged 50-71, enrolled in the NIH-AARP Diet and Health Study who completed a baseline epidemiologic questionnaire. Following a mean 9.3 years of follow-up, data were available for 1,486 incident endometrial cancer cases. Cox proportional hazards models were used to estimate associations of coffee with endometrial cancer incidence. Sub-group analyses were performed according to smoking status, hormone therapy use (HT) and body habitus. Coffee drinking was inversely related to incidence of endometrial cancer (hazard ratio [HR] comparing drinking of >3 cups/day versus no cups = 0.64, 95% CI, 0.51-0.80; P trend = 0.0004). The association of coffee with endometrial cancer risk was apparent for consumption of both regular (HR per cup = 0.90, 95% CI, 0.86-0.95) and decaffeinated coffee (HR per cup = 0.93, 95% CI, 0.87-0.99). The relation of coffee with endometrial cancer incidence varied significantly by HT use (P interaction = 0.03) with an association only apparent among HT-never users (HR comparing drinking >3 cups/day versus no cups = 0.54, 95% CI, 0.41-0.72; P trend = 0.0005). Endometrial cancer incidence appears to be reduced among women that habitually drink coffee, an association that does not differ according to caffeine content.

AB - Coffee drinking may be associated with reduced risk of endometrial cancer; however, prospective data are limited. Further, it is not clear whether any association between coffee and endometrial cancer differs according to coffee caffeine content. The association of coffee drinking with incidence of endometrial cancer was evaluated among 226,732 women, aged 50-71, enrolled in the NIH-AARP Diet and Health Study who completed a baseline epidemiologic questionnaire. Following a mean 9.3 years of follow-up, data were available for 1,486 incident endometrial cancer cases. Cox proportional hazards models were used to estimate associations of coffee with endometrial cancer incidence. Sub-group analyses were performed according to smoking status, hormone therapy use (HT) and body habitus. Coffee drinking was inversely related to incidence of endometrial cancer (hazard ratio [HR] comparing drinking of >3 cups/day versus no cups = 0.64, 95% CI, 0.51-0.80; P trend = 0.0004). The association of coffee with endometrial cancer risk was apparent for consumption of both regular (HR per cup = 0.90, 95% CI, 0.86-0.95) and decaffeinated coffee (HR per cup = 0.93, 95% CI, 0.87-0.99). The relation of coffee with endometrial cancer incidence varied significantly by HT use (P interaction = 0.03) with an association only apparent among HT-never users (HR comparing drinking >3 cups/day versus no cups = 0.54, 95% CI, 0.41-0.72; P trend = 0.0005). Endometrial cancer incidence appears to be reduced among women that habitually drink coffee, an association that does not differ according to caffeine content.

KW - chemoprevention

KW - coffee

KW - endometrial cancer

UR - http://www.scopus.com/inward/record.url?scp=84862530459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862530459&partnerID=8YFLogxK

U2 - 10.1002/ijc.26482

DO - 10.1002/ijc.26482

M3 - Article

C2 - 22021096

AN - SCOPUS:84862530459

VL - 131

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -